153 related articles for article (PubMed ID: 31570279)
21. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
Fletcher JA; Morton CC; Pavelka K; Lage JM
Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
[TBL] [Abstract][Full Text] [Related]
22. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.
Gannon BR; Manduch M; Childs TJ
Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978
[TBL] [Abstract][Full Text] [Related]
23. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
[TBL] [Abstract][Full Text] [Related]
24. Leiomyosarcoma: a rare malignant transformation of a uterine leiomyoma.
Di Luigi G; D'Alfonso A; Patacchiola F; Di Stefano L; Palermo P; Carta G
Eur J Gynaecol Oncol; 2015; 36(1):84-7. PubMed ID: 25872341
[TBL] [Abstract][Full Text] [Related]
25. Leiomyoma and Leiomyosarcoma (Primary and Metastatic) of the Oral and Maxillofacial Region: A Clinicopathological and Immunohistochemical Study of 27 Cases.
de Araújo GR; Costa SFDS; Mesquita RA; Gomez RS; Dos Santos JN; Pontes HAR; de Andrade BAB; Romañach MJ; Agostini M; Vargas PA; de Cáceres CVBL; Santos-Silva AR; Ribeiro ACP; Brandão TB; Tomasi RA; Ferreyra RS; de Almeida OP; Fonseca FP
Head Neck Pathol; 2022 Mar; 16(1):294-303. PubMed ID: 34106410
[TBL] [Abstract][Full Text] [Related]
26. Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissues.
Han K; Lee W; Harris CP; Simsiman RC; Lee K; Kang C; Meisner LF
Cancer Genet Cytogenet; 1994 May; 74(1):19-24. PubMed ID: 8194042
[TBL] [Abstract][Full Text] [Related]
27. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis.
Nakashima M; Suzuki K; Meirmanov S; Naruke Y; Matsuu-Matsuyama M; Shichijo K; Saenko V; Kondo H; Hayashi T; Ito M; Yamashita S; Sekine I
Int J Cancer; 2008 Mar; 122(5):1082-8. PubMed ID: 17985346
[TBL] [Abstract][Full Text] [Related]
28. Uterine Leiomyoma With Osteoclast-like Giant Cells.
Guilbert MC; Samouëlian V; Rahimi K
Int J Gynecol Pathol; 2016 Jan; 35(1):30-2. PubMed ID: 26166717
[TBL] [Abstract][Full Text] [Related]
29. Uterine smooth muscle tumours with hyperintense area on T
Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
[TBL] [Abstract][Full Text] [Related]
30. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.
Lakhman Y; Veeraraghavan H; Chaim J; Feier D; Goldman DA; Moskowitz CS; Nougaret S; Sosa RE; Vargas HA; Soslow RA; Abu-Rustum NR; Hricak H; Sala E
Eur Radiol; 2017 Jul; 27(7):2903-2915. PubMed ID: 27921159
[TBL] [Abstract][Full Text] [Related]
32. Uterine leiomyomas with bizarre nuclei: a clinicopathologic study of 59 cases.
Croce S; Young RH; Oliva E
Am J Surg Pathol; 2014 Oct; 38(10):1330-9. PubMed ID: 25140893
[TBL] [Abstract][Full Text] [Related]
33. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
34. Carcinosarcoma arising in a uterine leiomyoma: report of a unique neoplasm.
Collins DW; Menon PA; Carr JV; McCluggage WG
Int J Gynecol Pathol; 2011 Nov; 30(6):576-80. PubMed ID: 21979594
[TBL] [Abstract][Full Text] [Related]
35. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy.
Aminzadeh P; Alibrahim E; Dobrotwir A; Paul E; Goergen S
Br J Radiol; 2021 Mar; 94(1119):20200483. PubMed ID: 33507806
[TBL] [Abstract][Full Text] [Related]
37. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability.
Naruke Y; Nakashima M; Suzuki K; Matsuu-Matsuyama M; Shichijo K; Kondo H; Sekine I
Cancer Sci; 2008 May; 99(5):946-51. PubMed ID: 18380789
[TBL] [Abstract][Full Text] [Related]
38. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
[TBL] [Abstract][Full Text] [Related]
39. [Smooth muscle neoplasms of the uterus--a 51 cases study].
Wang M; Xu Y; Zhang T
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):263-5. PubMed ID: 9388867
[TBL] [Abstract][Full Text] [Related]
40. Leiomyoma with nuclear atypia: Rare diseases that present a common diagnostic problem.
Wei JJ
Semin Diagn Pathol; 2022 May; 39(3):187-200. PubMed ID: 35144823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
